NEWS
NEWS
Bayer to cut internal drug R&D work, axing hundreds of researchers while looking to partners as it unveils plan to slash 12,000 jobs
Bayer is pushing ahead with plans to restructure its drug R&D business and cut 900 research staffers as part of a broad plan to slash a total...
Novartis plans more ‘autonomy’ for Sandoz. But don’t confuse that with a spinoff: report
Just one day after Novartis laid out plans for its long-expected spinoff of its eye unit Alcon, the Swiss pharma giant found itself fending off a...
AbbVie’s Orilissa makes its uterine fibroids case with double phase 3 win
AbbVie’s Orilissa (elagolix) snagged its first FDA approval over the summer, and now it’s looking to make it two. On Wednesday, the Illinois...
FDA “Breakthrough” Ruling on Magic Mushrooms, Explained by Scientists
"This is an important advance in bringing these compounds out of the dark ages." The US Food and Drug Administration has given a group of...
Fight! Trump kicks off a war of words with the drug lobby, proposing to peg Medicare prices to overseas rates
President Donald Trump has just fired another shot across the bow of the global biopharma industry. And the industry quickly fired back in what...
LATEST NEWS
More anti-epidemic measures eased today
Bulgaria resumes the “green corridor” walk-in vaccination scheme
30,000 Bulgarians receive jabs against Covid-19 in last three days
CureVac’s mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage
COVID-19 vaccine players will split $100B in sales and $40B in profits, with Moderna leading the way: analyst
NEWS
Bayer to cut internal drug R&D work, axing hundreds of researchers while looking to partners as it unveils plan to slash 12,000 jobs
Bayer is pushing ahead with plans to restructure its drug R&D business and cut 900 research staffers as part of a broad plan to slash a total...
Novartis plans more ‘autonomy’ for Sandoz. But don’t confuse that with a spinoff: report
Just one day after Novartis laid out plans for its long-expected spinoff of its eye unit Alcon, the Swiss pharma giant found itself fending off a...
AbbVie’s Orilissa makes its uterine fibroids case with double phase 3 win
AbbVie’s Orilissa (elagolix) snagged its first FDA approval over the summer, and now it’s looking to make it two. On Wednesday, the Illinois...
FDA “Breakthrough” Ruling on Magic Mushrooms, Explained by Scientists
"This is an important advance in bringing these compounds out of the dark ages." The US Food and Drug Administration has given a group of...
Fight! Trump kicks off a war of words with the drug lobby, proposing to peg Medicare prices to overseas rates
President Donald Trump has just fired another shot across the bow of the global biopharma industry. And the industry quickly fired back in what...
LATEST NEWS
More anti-epidemic measures eased today
Bulgaria resumes the “green corridor” walk-in vaccination scheme
30,000 Bulgarians receive jabs against Covid-19 in last three days
CureVac’s mRNA coronavirus shot boasts one advantage over Pfizer and Moderna counterparts—refrigerated storage
COVID-19 vaccine players will split $100B in sales and $40B in profits, with Moderna leading the way: analyst